Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy
Category: News
The projects will focus on a range of research areas, including Down’s syndrome and ALS
The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines
The first phase of the programme will be in place in hospitals across the UK by March 2025
Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns
Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or […]
The proposals will help MedTech developers access NHS funding to fast-track products
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until […]